Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Eculizumab

EU orphan designation number: EU/3/12/1015
Active ingredient: Eculizumab
Indication: Treatment of infection-associated haemolytic uraemic syndrome
Sponsor: Alexion Europe SAS
1-15 avenue Edouard Belin, 92500 Rueil-Malmaison, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/07/2012 Orphan designation EMA/OD/013/12 (2012)4769 of 04/07/2012
20/02/2015 Change of name and/or address of sponsor
20/07/2015 Removal of orphan designation from Community Register